Skip to main content
. 2020 Nov 12;13:577–584. doi: 10.2147/PGPM.S270319

Table 4.

Clinical Outcome Correlation of NTRK2 Polymorphisms with is Patients

Feature Genotype (rs11140793) AC vs AA*
P value
CC vs AA*
P value
AA AC CC
NIHSS ac (Mean/SD) 3.1/1.1 4.2/1.5 4.8/1.1 0.02 0.005
NIHSS 3m (Mean/SD) 0.6/0.1 0.8/0.2 1.1/0.2 0.03 0.002
tHcy (mmol/L) 12.3/1.8 13.5/1.5 15.5/1.4 0.01 0.001
NTRK2 (Mean/SDb) 0.08/0.022 0.06/0.018 0.04/0.11 0.02 0.003
Feature Genotype (rs7047042) CG vs CC*
P value
GG vs CC*
P value
CC CG GG
NIHSS ac (Mean/SD) 3.2/1.1 3.5/1.3 4.1/2.1 0.04 0.02
NIHSS 3m (Mean/SD) 0.7/0.1 0.9/0.2 1.0/0.2 0.03 0.01
tHcy (mmol/L) 11.8/1.9 12.1/1.6 14.2/1.8 0.01 0.04
NTRK2 (Mean/SDb) 0.09/0.012 0.06/0.021 0.04/0.19 0.02 0.03
Feature Genotype (rs1221) CT vs CC*
P value
TT vs CC*
P value
CC CT TT
NIHSS ac (Mean/SD) 3.5/1.1 3.6/1.7 4.2/2.1 0.12 0.03
NIHSS 3m (Mean/SD) 1.1/0.4 1.1/0.6 1.3/0.8 0.23 0.02
tHcy (mmol/L) 10.8/1.9 13.2/0.2 13.1/0.3 0.001 0.002
NTRK2 (Mean/SDb) 0.06/0.032 0.03/0.021 0.01/0.011 0.01 0.03

Notes: *Student t-test for either genotype distributions or allele frequencies in IS patients. bRelative expression of NTRK2 normalized with GAPDH. NIHSS ac, initial stroke severity during the acute phase; NIHSS 3m, stroke severity after 3 months; MTHFR: Relative expression of MTHGR mRNA in IS patients.